FOLFOX

Results: 45



#Item
1Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

Add to Reading List

Source URL: www.medicines.org.uk

Language: English
2Bevacizumab+ FOLFOX  (f.d.OxModdG) (colorektal) Bevacizumab (Avastin) 5 mg/kg (om lämpligt, jämna 100-tal) iv infmin iv infmin

Bevacizumab+ FOLFOX (f.d.OxModdG) (colorektal) Bevacizumab (Avastin) 5 mg/kg (om lämpligt, jämna 100-tal) iv infmin iv infmin

Add to Reading List

Source URL: www.cancercentrum.se

Language: Swedish - Date: 2012-11-02 03:29:05
    3Cetuximab/FOLFOX Cetuximab Oxaliplatin Calciumfolinat 5-Fluorouracil 5-Fluorouracil

    Cetuximab/FOLFOX Cetuximab Oxaliplatin Calciumfolinat 5-Fluorouracil 5-Fluorouracil

    Add to Reading List

    Source URL: www.cancercentrum.se

    Language: Swedish - Date: 2012-11-02 04:03:55
      4Bristol-Myers Squibb / Cetuximab / Panitumumab / KRAS / Bevacizumab / Immune system / Oxaliplatin / Colorectal cancer / FOLFOX / Medicine / Chemistry / Pharmacology

      7.5 PANITUMUMAB, injection, 100 mg/5 mL and 400 mg/20 mL, Vectibix®, Amgen Australia Pty Ltd. Purpose of Application To request that the current Section 100 (Efficient Funding of Chemotherapy Program) Authority Require

      Add to Reading List

      Source URL: www.pbs.gov.au

      Language: English - Date: 2015-04-22 23:39:46
      5PAR Oxaliplatin 5 mg / ml Concentrate for Solution for Infusion  PL; UK/HDC Public Assessment Report Decentralised Procedure

      PAR Oxaliplatin 5 mg / ml Concentrate for Solution for Infusion PL; UK/HDC Public Assessment Report Decentralised Procedure

      Add to Reading List

      Source URL: www.mhra.gov.uk

      Language: English - Date: 2010-03-29 07:13:09
      6DOI: jimabJournal of IMAB - Annual Proceeding (Scientific Papers) 2008, vol. 14, book 1 IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER Deyan Davidov Department

      DOI: jimabJournal of IMAB - Annual Proceeding (Scientific Papers) 2008, vol. 14, book 1 IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER Deyan Davidov Department

      Add to Reading List

      Source URL: www.journal-imab-bg.org

      Language: English - Date: 2011-11-02 17:53:47
      7Vectibix PI Appendix 2 (PI)

      Vectibix PI Appendix 2 (PI)

      Add to Reading List

      Source URL: www.ema.europa.eu

      Language: English - Date: 2015-03-02 10:30:33
      8Overall survival in all RAS wild type patients in CALGB/SWOGstudy

      Overall survival in all RAS wild type patients in CALGB/SWOGstudy

      Add to Reading List

      Source URL: www.pbs.gov.au

      Language: English - Date: 2015-03-16 01:05:14
      9   FOR IMMEDIATE RELEASE A DOSE OF REALITY ABOUT CHEMOTHERAPY DOSING SALADAX HAS THE ANTIDOTE – MY5-FU™ Bethlehem, PA – March 19, Saladax Biomedical, Inc. announced today that Saladax

        FOR IMMEDIATE RELEASE A DOSE OF REALITY ABOUT CHEMOTHERAPY DOSING SALADAX HAS THE ANTIDOTE – MY5-FU™ Bethlehem, PA – March 19, Saladax Biomedical, Inc. announced today that Saladax

      Add to Reading List

      Source URL: www.saladax.com

      Language: English - Date: 2014-03-19 20:15:45
      10切除不能大腸癌に対する5-FU/l-LV/oxaliplatin (FOLFOX) +bevacizumab とTS-1/oxaliplatin (SOX) + bevacizumab とのランダム化比較第Ⅲ相試験(SOFT)

      切除不能大腸癌に対する5-FU/l-LV/oxaliplatin (FOLFOX) +bevacizumab とTS-1/oxaliplatin (SOX) + bevacizumab とのランダム化比較第Ⅲ相試験(SOFT)

      Add to Reading List

      Source URL: www.taiho.co.jp

      Language: Japanese - Date: 2012-01-23 21:10:53